DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
Companies / S••••• T•••••••••
S••••• T•••••••••
Series AUS
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- unknown
- Rounds on record
- 1
- Disclosed raised
- $18.0Msum of rounds with a disclosed amount only
- Named investors
- 2
Financing history
1 rounds
- Apr 15, 2026Series A · $18.0M (disclosed)S•••• V••••••• (lead)F••• T•••• I••••••••• (participant)Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “S••••• T••••••••• Closes $18 Million Series A Financing to Advance Breakthrough HIFU Therapy for Pancreatic Cancer, Expands U.S. Clinical Development”
Investors on record
2 edges
- F••• T•••• I••••••••• round, participant Fact prnewswire.com
- S•••• V••••••• round, lead Fact prnewswire.com
People
0 officers, 0 directors
No officer or director on record.
Timeline
1
- Apr 15, 2026S••••• T••••••••• announced Series A of $18,000,000, led by Santé VenturesRound announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
Evidence
1 observations
Every observation on this company
- Round announced: Series A $18,000,000 Apr 15, 2026 Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)